HC Wainwright & Co. reiterated coverage on Oncternal Therapeutics with a new price target

3/12/21 6:43:54 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. reiterated coverage of Oncternal Therapeutics with a rating of Buy and set a new price target of $9.00 from $8.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ONCT

Date	Price Target	Rating	Analyst
2/24/2022	$5.00	Buy	BTIG
2/24/2022	$50.00	Buy	BTIG